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Abstracts
Gregory L. Moneta, MD, Section EditorClinical Outcomes of Carotid Endarterectomy in Patients
With Carotid Artery Tandem Lesions
Han Y, Park H, Kwon SU, et al. Stroke 2014;45:3443-6.
Conclusions: Patients undergoing carotid endarterectomy with the
diagnosis of tandem carotid stenosis by contrast-enhanced magnetic reso-
nance angiography have similar rates of stroke and death with and without
tandem stenosis.
Summary: There have been previous studies evaluating the outcomes
of carotid endarterectomy in patients with both intracranial and extracranial
carotid artery disease. Most such studies were published more than 15 years
ago using intra-arterial digital subtraction angiography for diagnosis of ca-
rotid lesions. The authors sought to reevaluate outcomes of carotid endar-
terectomy in patients with extracranial and combined intracranial carotid
artery stenosis in the modern era where the use of noninvasive diagnostic
modalities such as Duplex ultrasonography and contrast-enhanced magnetic
resonance angiography are primarily used in the planning of carotid endar-
terectomy. There were 647 consecutive patients who underwent CEA be-
tween January 2001 and December 2010. Tandem stenosis, deﬁned as a
signiﬁcant carotid bifurcation stenosis and identiﬁable stenosis of $50% of
any downstream distal cerebral artery was identiﬁed in 92 patients
(14.2%) by contrast enhanced magnetic resonance angiography. Patients
with and without tandem stenosis were compared in terms of CEA out-
comes. Primary end point was the composite of any stroke, myocardial
infarction, or death during the periprocedular period or ipsilateral stroke
within 4 years after the CEA. The two groups did not differ in terms of esti-
mated 4-year primary endpoint rates (8.7% vs 3.8%; P ¼ .07) for ipsilateral
stroke-free (P ¼ .56), any strokeefree (P ¼ .89), or overall survival
(P ¼ .41).
Comment: The study conﬁrms the frequency with which tandem le-
sions are observed in patients undergoing CEA (14.2%) and the fact that
tandem lesions are not associated with an increased risk of ipsilateral stroke
during follow-up after CEA. The only really unique feature of the study is
that it is more modern than previous studies and that the diagnosis of intra-
cranial stenosis was made in a different fashion using MRA rather than cath-
eter based contrast angiography.Global Sodium Consumption and Death From
Cardiovascular Causes
Mozaffarian D, Fahimi S, Singh GM, et al. N Engl J Med 2014;371:624-34.
Conclusions: There were 1.65 million deaths from cardiovascular
causes in 2010 attributable to sodium consumption above a reference level
of 2.0 g per day.
Summary: Increased intake of dietary sodium is associated with
elevated blood pressure and adverse cardiovascular outcomes (Frieden
TR et al, N Engl J Med 2011;365:e27). However, global effects of sodium
consumption and the effects according to age, sex, and country have not
been clearly established. The authors collected data from surveys on so-
dium intake as determined by urinary excretion and diet in persons from
66 countries (accounting for 74.1% of adults throughout the world).
The data was then used to quantify global consumption of sodium accord-
ing to age, sex, and country. Effects of sodium on blood pressure accord-
ing to age, race, and the presence or absence of hypertension were
calculated from data in a new meta-analysis of 107 randomized interven-
tions, and the effects of blood pressure on cardiovascular mortality,
according to age, were calculated from a meta-analysis of cohorts.
Cause-speciﬁc mortality was then derived from the Global Burden of Dis-
ease Study 2010. Using comparative risk assessment an estimate of the car-
diovascular effects of current sodium intake as compared with the
referenced intake of 2.0 g of sodium per day according to age, sex, and
country was determined. In 2010 the estimated mean level of global so-
dium consumption was 3.95 g per day, and the regional mean levels
ranged from 2.18 to 5.51 g per day. Globally, 1.65 million annual deaths
from cardiovascular causes (95% uncertainty interval [conﬁdence interval],
1.10 million to 2.22 million) were attributed to sodium intake above the
reference level; 61.9% of these deaths occurred in men and 38.1% occurred
in women. These deaths accounted for nearly 1of every 10 deaths from
cardiovascular causes (9.5%). Four of every 5 deaths (84.3%) occurred inlow- and middle-income countries and two of every ﬁve deaths (40.4%)
were premature (before 70 years of age).
Comment: The data indicate that no region and few countries are
spared from the adverse effect of increased sodium consumption on cardio-
vascular death. The data, however, depends upon extrapolating the effects
of sodium on blood pressure to cardiovascular risks. Although this is not
deﬁnitively established, the effect on cardiovascular disease from hyperten-
sion and the effects of sodium consumption on hypertension are supported
by extensive experimental and demographic evidence. A meta-analysis of 37
trials has shown no signiﬁcant adverse effects on blood lipid levels, catechol-
amine levels or renal function from decreased sodium consumption (Aburto
NJ et al, BMJ 2013;346:f1326). Therefore it appears there is nothing to be
lost and potentially much to be gained by decreasing sodium consumption
for adults to less than 2 g per day.Improved Quality of Life After 1 Year With an Invasive
Versus a Noninvasive Treatment Strategy in Claudicants:
One-Year Results on the Invasive Revascularization or
Not in Intermittent Claudication (IRONIC) Trial
Nordanstig J, Taft C, Hensäter M, et al. Circulation 2014;130:939-47.
Conclusions: An invasive treatment strategy improves health-related
quality of life and intermittent claudication distance after 1 year in patients
with stable lifestyle-limiting claudication receiving current medical
management.
Summary: Patients with intermittent claudication are at increased risk
for cardiovascular events, cerebrovascular events and premature death but
are at low risk of limb loss. Many claudicants will respond with increased
walking distance with exercise training, thus risk factor modiﬁcation and
medical treatment and exercise training are standard and accepted ﬁrst-
line treatments of patients with intermittent claudication (IC). However ex-
ercise training under supervision is not often available for many patients and
many others are poorly compliant with supervised exercise. Evidence for the
effectiveness of invasive treatment for intermittent claudication is relatively
sparse. Most studies evaluating invasive treatment have used selective inclu-
sion criteria enrolling patients on the basis of vascular lesions (ie, in speciﬁc
vessel segments or lesions of certain length and severity with suitable anat-
omy for endovascular treatment). A long list of exclusion criteria in such
studies has made it difﬁcult to generalize results to the majority of patients
with intermittent claudication. Based on all of this the authors sought to
perform what they term “a real world” study to test the hypothesis that
an invasive (surgical or endovascular) treatment strategy compared with
continued medical therapy would improve health-related quality of life in
relatively unselected IC patients already receiving best medical treatment
and structured (nonsupervised) exercise training advice. Patients with inter-
mittent claudication underwent clinical and ultrasound assessment and
those requesting treatment for claudication were then randomly assigned
to invasive (n ¼ 79) or noninvasive (n ¼ 79) treatment groups. The primary
endpoint was health-related quality of life after 1 year assessed with the
Medical Outcomes Study Short Form 36 version 1 and Vascular Quality
of Life Questionnaire. Secondary endpoints included walking distance on
a graded treadmill. The Medical Outcomes Short Form 36 version 1 phys-
ical components and 2 Medical Outcomes Study Short Form 36 version
1 physical subscales improved signiﬁcantly more in the invasive vs the nonin-
vasive group (P < .001). Vascular Quality of Life Questionnaire score
(P < .01) and 3 of 5 domain scores improved signiﬁcantly more in the inva-
sive vs the noninvasive group. Intermittent claudication distance improved
more in the invasive (+124 m) vs the noninvasive (+50 m) group (P ¼
.003). Change in maximum walking distance was not signiﬁcantly different
between groups.
Comment: There are several innovative elements in this trial’s study
design, the primary one of which is to use the health-related quality of
life as the primary end point. Most claudication trials have used patency
of reconstructions, and treadmill walking distance as primary endpoints in
evaluation of treatments for claudication. Beneﬁts in health-related quality
of life may include many elements and not just leg symptoms. The concept
of patient-centered outcomes is becoming increasingly prevalent in clinical
trials. To test the unique approach presented in this trial it also will need
to be evaluated in additional studies incorporating longer follow-up and567
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accepted optimal treatment for intermittent claudication.Metabolic Syndrome Predicts Restenosis After Carotid
Endarterectomy
Williams WT, Assi R, Hall MR, et al. J Am Coll Surg 2014;219:771-7.
Conclusions: Metabolic syndrome is an independent predictor for
restenosis after carotid endarterectomy (CEA).
Summary: In modern studies, restenosis after endarterectomy for
symptomatic severe carotid artery stenosis occurs at a rate of 5% at 3 years
(Arquizan C et al, Stroke 2011;42:1015-20). Other studies suggest that
at 15 years after CEA rates of stroke associated with restenosis may be as
high as 50% (Fluri F et al, Cerebrovasc Dis 2008;26:654-8). Obviously
restenosis after CEA therefore has the potential to lead to additional inter-
ventions and adverse outcomes. Factors predicting restenosis after CEA
however, are poorly understood. The purpose of this study was to examine
which risk factors are potentially associated with restenosis after CEA. This is
a retrospective study that examined the records of all patients who under-
went CEA at the Veterans Affairs Connecticut Healthcare System during
a 4-year period. Metabolic syndrome was deﬁned as the presence of 3 or
more of the following: hypertension as deﬁned by a blood pressure
$130 mmHg; serum triglycerides $150 mg/dl; high-density lipoprotein
$40 mg/dl; BMI $25 kg/m2; and fasting blood glucose$ 10 mg/dl. Ma-
jor adverse events were deﬁned as stroke, death or MI. Restenosis was
deﬁned as >50% stenosis on follow-up imaging studies. There were 78 pa-
tients who underwent 79 CEAs during the study period. All patients were
male and 76% were Caucasian. Mean age was 72.6 years. Mean duration
of follow-up was 5.2 years. 67% of patients had metabolic syndrome. Pa-
tients with metabolic syndrome were comparable with those without meta-
bolic syndrome in demographics and preoperative comorbidities except for
increased hypertension and diabetes, as expected, and in chronic renal insuf-
ﬁciency (P ¼ .05). There was no signiﬁcant difference in long-term survival
or freedom from major adverse events between patients with and without
metabolic syndrome. However, restenosis was signiﬁcantly higher in pa-
tients with metabolic syndrome (P ¼ .02) and occurred 2 years after CEA
in patients with metabolic syndrome only, with a large increase in restenosis
after 5 years (P ¼ .018). In a multivariable analysis metabolic syndrome
remained an independent predictor of restenosis (P ¼ .01).
Comment: Most studies examining the rate of restenosis following
carotid endarterectomy have shorter periods of follow-up than exhibited
here. Although in this small study the authors were unable to demonstrate
a difference in major adverse events in the patients with metabolic syndrome
vs those without metabolic syndrome, an anatomic goal of carotid endarter-
ectomy is to maintain patency of the artery without restenosis. The data
does not allow it to be determined whether control of the individual com-
ponents of the metabolic syndrome around the time of endarterectomy
would reduce late restenosis. It appears patients with metabolic syndrome
at the time of CEA are at risk for restenosis and thus could constitute a
group of patients for whom more frequent and-or long-term surveillance
is warranted. In addition such patients may serve as a target for even
more intensive medical management of the individual components of their
metabolic syndrome at the time of their original operation.Preventable Readmissions to Surgical Services: Lessons
Learned and Targets for Improvement
Dawes AJ, Sacks GD, Russell MM, et al. J Am Coll Surg 2014;219:382-9.
Conclusions: A minority of readmissions may potentially be prevent-
able. Policies aimed at penalizing reimbursements based on readmission
rates should use clinical data to focus on inappropriate hospitalization as a
measure to promote high quality patient care.
Summary: Vascular surgical patients have overall high readmission
rates compared to many other types of patients. As a measure of health
care quality, hospital readmissions are a prominent focus currently. The
Center for Medicare and Medicaid Services (CMS) proposes using readmis-
sion rates as a benchmark to improve care, including targeting them as non-
reimbursable events. The study here was designed to describe potentially
preventable readmissions after surgery and identify targets for improvement.
The study focused on patients discharged from a surgical service over 8
consecutive quarters (Q4 2009 to Q3 2011). A working group of attending
surgeons deﬁned terms and created classiﬁcation schemes. Thirty-day read-
missions were identiﬁed and reviewed by a 2-physician team. Readmissions
were then categorized as unpreventable or preventable, and as targets for
future quality improvement intervention. Overall readmission rate was
8.3% (315 of 3789 admissions). The most common indication for initial
admission was elective surgery. Among admitted patients in the sample,
28% did not undergo an operation during their index admission. Only21% (55 of 258) of readmissions were likely preventable based on medical
record review. Of the preventable readmissions, 38% of patients were dis-
charged within 24 hours and 60 % within 48 hours. Dehydration occurred
more frequently among preventable readmissions (P < .001). Infection
accounted for more than one-third of all readmissions. Preventable readmis-
sions targets for improvement included closer follow-up after discharge
(49%), management of the outpatient setting (42%), and avoidance of pre-
mature discharge (9%).
Comment: It is very likely that the complexity of medical care will
preclude total elimination of readmissions. Many readmissions actually
reﬂect clinically appropriate care delivery and of course some reﬂect unnec-
essary or inappropriate care or discretionary events. This paper is a step in
the right direction in that indicates that treating all readmissions as unavoid-
able events is likely not practical or realistic. Efforts should be geared toward
distinguishing preventable from unpreventable readmissions to promote the
overall goal of delivery of high-quality care.Intraplaque Hemorrhage, Fibrous Cap Status, and
Microembolic Signals in Symptomatic Patients With Mild
to moderate Carotid Artery Stenosis: The Plaque At RISK
Study
Truijman MTB, de Rotte AAJ, Aaslid R, et al. Stroke 2014;45:3423-6.
Conclusions: In patients with symptomatic mild to moderate carotid
artery stenosis, intraplaque hemorrhage (IPH) and the status of the ﬁbrous
cap (FC) are not associated with microbembolic signals (MES) as deter-
mined by transcranial Doppler (TCD). MRI and TCD therefore likely pro-
vide different information on plaque vulnerability.
Summary: The primary way of estimating risk of a carotid artery pla-
que is the degree of stenosis. However, there are other plaque characteristics
that may be important as well. Detection of plaques which are prone to
rupture, so-called vulnerable plaques, may help to determine the best ther-
apeutic approach to patients with carotid stenosis, especially patients with
mild to moderate carotid artery stenosis. In patients with mild to moderate
symptomatic carotid artery stenosis increased risk of stroke or recurrent
stroke has been associated with IPH and a thin/ruptured FC as evaluated
by MRI, and MES detected with TCD. In this study the authors sought
to determine whether the presence of MES differs in patients with and
without IPH and a thin/ruptured FC, vs patients with only a thin/ruptured
FC but without IPH. This is a multicenter, diagnostic cohort study. Patients
(n ¼ 113) with recent transient ischemic attack (TIA) or minor stroke in the
carotid territory and ipsilateral mild to moderate carotid artery plaque were
included. IPH and FC status were dichotomously scored. TCD data was
analyzed blinded to results of MRI. TCD measurements were feasible in
105/113, with an average recording time of 219 minutes. A total of 26
MESs were detected in 8 of 105 patients. In 44 of 105 plaques IPH was
present. In 92 of 105 plaques FC status was assessable and 36 of these
had a thin/ruptured FC. There was no signiﬁcant difference in the preva-
lence of MES between patients with and without IPH (P ¼ .46) or those
with thick vs thin/ruptured FC (P ¼ .48).
Comment: The study differs from a previous study that correlated a
signiﬁcant relationship between MES occurrence and the presence of a
vulnerable plaque on MRI. Patients in that study (Altaf N, et al. Radiology
2011; 258:538-545) had high-grade carotid stenosis compared to mild to
moderate carotid artery stenosis in the patients in the current study. It
maybe, that the mircroembolic potential of a vulnerable plaque is enhanced
by the ﬂow effects induced by high-grade carotid stenosis. One wonders
whether the “vulnerable” plaque in isolation in the carotid circulation is
really all that important and only becomes important when associated
with signiﬁcant stenosis. Longer term data focusing on clinical outcomes
rather than just analysis of MES signals is needed to answer this sort of
question.Long-Term Follow-Up Study of Endarterectomy Versus
Angioplasty in Patients With Symptomatic Severe Carotid
Stenosis Trial
Mas JL, Arquizan C, Calvet D, EVA-3S Investigators. Stroke 2014;45:
2750-6.
Conclusions: The long-term risk-beneﬁt of carotid stenting (CAS) vs
endarterectomy (CEA) for symptomatic carotid stenosis favors CEA and the
difference is driven by lower risk of procedural stroke after CEA compared
to CAS.
Summary: This study presents long-term follow-up of patients
included in the endarterectomy vs angioplasty in patients with symptomatic
severe carotid artery stenosis (EVA-3S) trial. This is a randomized control
trial of CAS vs CEA in 527 patients who had had recently symptomatic se-
vere carotid stenosis. The trial was conducted in 30 centers in France and
